XPDB - ACADIA Pharmaceuticals Ocular Therapeutix Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session | Benzinga
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining by around 50 points on Tuesday.
Shares of ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) fell sharply in today’s pre-market trading after the company reported the Phase 3 ADVANCE-2 trial evaluating pimavanserin for the treatment of negative symptoms of schizophrenia did not meet the primary endpoint.
ACADIA Pharmaceuticals shares dipped 17.4% to $19.93 in pre-market trading.
Here are some big stocks recording losses in today’s pre-market trading session.
- Power & Digital Infrastructure Acquisition II Corp. (NASDAQ: XPDB) shares tumbled 12.6% to $25.57 in pre-market trading after surging ...